AVITA Medical (FRA:51KB) Current Accrued Expense : €7.72 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical Current Accrued Expense?

AVITA Medical's Current Accrued Expense for the quarter that ended in Mar. 2025 was €7.72 Mil.

AVITA Medical's quarterly Current Accrued Expense increased from Sep. 2024 (€8.81 Mil) to Dec. 2024 (€9.98 Mil) but then declined from Dec. 2024 (€9.98 Mil) to Mar. 2025 (€7.72 Mil).

AVITA Medical's annual Current Accrued Expense increased from Dec. 2022 (€6.25 Mil) to Dec. 2023 (€7.31 Mil) and increased from Dec. 2023 (€7.31 Mil) to Dec. 2024 (€9.98 Mil).

AVITA Medical Current Accrued Expense Historical Data

The historical data trend for AVITA Medical's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Current Accrued Expense Chart

AVITA Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

2.50

2.76

6.25

7.31

9.98

AVITA Medical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial															5.34	7.08	8.81	9.98	7.72

AVITA Medical Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

AVITA Medical Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (FRA:51KB) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

RCEL:USA AVHHL:USA AVH:Australia

Address

28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

AVITA Medical Headlines

No Headlines